HVIA
JAZZ icon

Hudson Valley Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hudson Valley Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,000
Closed -$880K – 156
2015
Q2 		$880K Buy
+5,000
New +$898K 0.27% 78

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hudson Valley Investment Advisors's JAZZ Position: Q3 2015 in Review

Hudson Valley Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2015, closing a stake of 5,000 shares — an estimated $880K sold.

Hudson Valley Investment Advisors first reported a position in JAZZ in Q2 2015 and held it in 1 quarter. The position peaked at $880K in Q2 2015. 361 funds tracked by Wall St. Rank hold JAZZ as of Q3 2015.

  • Hudson Valley Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Hudson Valley Investment Advisors sold 5,000 Jazz Pharmaceuticals shares in Q3 2015, an estimated $880K.
  • Hudson Valley Investment Advisors first reported a position in Jazz Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Hudson Valley Investment Advisors's Jazz Pharmaceuticals position peaked at $880K in Q2 2015.
  • 361 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2015.

Based on Hudson Valley Investment Advisors's 13F filing for Q3 2015, filed 16 Oct 2015.